抗乙型肝炎免疫核酸联合玄驹口服液对乙型肝炎病毒复制标志物的影响  

Effects of Anti-hepatitis B Viral Immune Ribonucleic Acid Combined Qiang Lichun Oral Juice on Hepatitis B Viral Reproducible Mark

作　　者：商永珍 冯玉鑫[2] 陈秋云[2] 

机构地区：[1]湖北医科大学附一医院传染科,武汉430060 [2]湖北医科大学附一医院保健科,武汉430060

出　　处：《湖北医科大学学报》1996年第1期81-82,共2页

摘　　要：抗乙型肝炎免疫核糖核酸联合玄驹口服液治疗乙型肝炎病毒(HBV)感染病人28例;另单用抗乙肝免疫核糖核酸治疗同样病情者27例为对照,半年之内观察乙型肝炎病毒标志物(HBVm)的影响,结果治疗组 HBeAg、HBV-DNA 阴转率分别为48.6%,42.8%;对照组分别为16.4%,0%,治疗组与对照组比较差异有高度显著性(P<0.01)。28 chronic HBV infectiou cases serving as treatment group were adminitered with anti-hep- atitis B immune ribonucleic acid (Anti-HBV IRNA) combined with Qiang Lichun oral juice.At the same time,27 eases serving as control group with the same disease were only treated with Anti-HBV IRNA.Observation of hepatitis B viral reproducible mark was performed within six months.The results were that the negative percentage of HBeAg and HBV-DNA in the treatment group was 48.6% and 42.8% respectively,while in the control group it was 16.4% and 0% re- spectively.There was a significant difference between the two groups (P<0.01).There was no side effects during the treatment.

关 键 词：乙型肝炎 中西医结合治疗 玄驹口服液 免疫RNA 

分 类 号：R512.620.5[医药卫生—内科学]